A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 530 participants.
Also called NCT02017171
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 530 participants
- Sponsor
- Albert Einstein College of Medicine
- Emory University
- Juvenile Diabetes Research Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
- Northwestern University
- Steno Diabetes Center Copenhagen
- University of Alberta
- University of Calgary
- University of Colorado, Denver
- University of Michigan
- University of Minnesota
- University of Texas Southwestern Medical Center
- University of Toronto
- University of Washington
- Washington University School of Medicine
- Registry
-
NCT02017171
-
- Other papers using this trial's data
- Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Denmark
- Registry status
- Completed
Technical summary
Registry record NCT02017171. Randomized; triple masking; primary purpose prevention. Start 2014-02 (actual); primary completion 2019-07-15 (actual). Results posted on 2020-11-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
- Condition
- Diabetic Nephropathies
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Allopurinol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Alessandro Doria
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator
- Juvenile Diabetes Research Foundation
- Collaborator
- Joslin Diabetes Center
- Collaborator
- University of Minnesota
- Collaborator
- University of Colorado, Denver
- Collaborator
- University of Michigan
- Collaborator
- University of Toronto
- Collaborator
- Northwestern University
- Collaborator
- Albert Einstein College of Medicine
- Collaborator
- Steno Diabetes Center Copenhagen
- Collaborator
- Washington University School of Medicine
- Collaborator
- University of Washington
- Collaborator
- Emory University
- Collaborator
- University of Calgary
- Collaborator
- University of Alberta
- Collaborator
- University of Texas Southwestern Medical Center
- Collaborator
- BCDiabetes.Ca
Registry records
Assembled by a program from ROR and ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry organizations 14
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 30 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 22 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 25 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 25 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 17 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 20 trials in this atlas.
-
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 11 trials in this atlas.
Record details
- Record id
cardio:ct-nct02017171- Content hash
a0f519d97a978d565273378c33d1bb4933ed3a0052674e1581e1c3d03f7bb14b